US Patent Issued to Shuttle Pharmaceuticals on July 15 for "Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation" (Maryland Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,650, issued on July 15, was assigned to Shuttle Pharmaceuticals Inc. (Rockville, Md.).

"Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation" was invented by Scott Grindrod (Rockville, Md.), Mira Jung (Rockville, Md.), Olga Timofeeva (Rockville, Md.), Milton Brown (Rockville, Md.) and Anatoly Dritschilo (Rockville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and formulations are provided for treating cancer and neoplastic diseases in conjunction with radiation therapy where such methods and formulations include a combination ...